Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 516981, 10 pages
http://dx.doi.org/10.1155/2012/516981
Review Article

Cancer Chemoprevention by Citrus Pulp and Juices Containing High Amounts of β-Cryptoxanthin and Hesperidin

1The Tohkai Institute of Cytopathology: Cancer Research and Prevention, 5-1-2 Minami-uzura, Gifu City, Gifu 500-8285, Japan
2Department of Tumor Pathology, Graduate School of Medicine, Gifu University, Gifu City, Gifu 501-1194, Japan
3Department of Physical Therapy, Kansai University of Health Sciences, 2-11-1 Wakaba, Kumatori-Machi, Sennan-Gun, Osaka 590-0482, Japan
4Department of Pharmacy, Kinjo Gakuin University, 2-1723 Ohmori, Moriyama-Ku, Nagoya City, Aichi 463-8521, Japan

Received 26 July 2011; Accepted 29 August 2011

Academic Editor: Masa-Aki Shibata

Copyright © 2012 Takuji Tanaka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. E. Johnson, “Second lung cancers in patients after treatment for an initial lung cancer,” Journal of the National Cancer Institute, vol. 90, no. 18, pp. 1335–1445, 1998. View at Google Scholar · View at Scopus
  2. T. Tanaka and R. Ishigamori, “Understanding carcinogenesis for fighting oral cancer,” Journal of Oncology, vol. 2011, Article ID 603740, 2011. View at Publisher · View at Google Scholar · View at PubMed
  3. T. Tanaka, M. Tanaka, and T. Tanaka, “Oral carcinogenesis and oral cancer chemoprevention: a review,” Pathology Research International, vol. 2011, Article ID 431246, 2011. View at Publisher · View at Google Scholar
  4. T. Tanaka, “Chemoprevention of oral carcinogenesis,” European Journal of Cancer Part B, vol. 31, no. 1, pp. 3–15, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Tanaka, “Chemoprevention of human cancer: biology and therapy,” Critical Reviews in Oncology/Hematology, vol. 25, no. 3, pp. 139–174, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Tanaka, “Effect of diet on human carcinogenesis,” Critical Reviews in Oncology/Hematology, vol. 25, no. 2, pp. 73–95, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Greenwald, G. J. Kelloff, C. W. Boone, and S. S. McDonald, “Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents,” Cancer Epidemiology Biomarkers and Prevention, vol. 4, no. 7, pp. 691–702, 1995. View at Google Scholar · View at Scopus
  8. G. J. Kelloff, C. W. Boone, J. A. Crowell, V. E. Steele, R. Lubet, and C. C. Sigman, “Chemopreventive drug development: perspectives and progress,” Cancer Epidemiology Biomarkers and Prevention, vol. 3, no. 1, pp. 85–98, 1994. View at Google Scholar · View at Scopus
  9. D. E. Corpet and S. Taché, “Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency,” Nutrition and Cancer, vol. 43, no. 1, pp. 1–21, 2002. View at Google Scholar · View at Scopus
  10. G. J. Kelloff, C. W. Boone, J. A. Crowell et al., “New agents for cancer chemoprevention,” Journal of Cellular Biochemistry, vol. 26, supplement, pp. 1–28, 1996. View at Google Scholar · View at Scopus
  11. T. Tanaka and H. Mori, “Inhibition of colon carcinogenesis by non-nutritive constituents in foods,” Journal of Toxicologic Pathology, vol. 9, pp. 139–149, 1995. View at Google Scholar
  12. T. Tanaka and S. Sugie, “Inhibition of colon carcinogenesis by dietary non-nutritive compounds,” Journal of Toxicologic Pathology, vol. 20, no. 4, pp. 215–235, 2008. View at Publisher · View at Google Scholar
  13. H. Faure, V. Fayol, C. Galabert et al., “Carotenoids: 1. Metabolism and physiology,” Annales de Biologie Clinique, vol. 57, no. 2, pp. 169–183, 1999. View at Google Scholar · View at Scopus
  14. T. Tanaka, H. Sugiura, R. Inaba et al., “Immunomodulatory action of citrus auraptene on macrophage functions and cytokine production of lymphocytes in female BALB/c mice,” Carcinogenesis, vol. 20, no. 8, pp. 1471–1476, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Nishino, H. Tokuda, M. Murakoshi et al., “Cancer prevention by natural carotenoids,” BioFactors, vol. 13, no. 1-4, pp. 89–94, 2000. View at Google Scholar · View at Scopus
  16. T. Narisawa, Y. Fukaura, S. Oshima, T. Inakuma, M. Yano, and H. Nishino, “Chemoprevention by the oxygenated carotenoid β-cryptoxanthin of N-methylnitrosourea-induced colon carcinogenesis in F334 rats,” Japanese Journal of Cancer Research, vol. 90, no. 10, pp. 1061–1065, 1999. View at Google Scholar · View at Scopus
  17. H. Kohno, M. Maeda, S. Honjo et al., “Prevention of colonic preneoplastic lesions by the beta-cryptoxanthin and hesperidin rich powder prepared from Citrus Unshiu Marc. Juice in male F344 rats,” Journal of Toxicologic Pathology, vol. 12, pp. 209–215, 1999. View at Google Scholar
  18. H. Kohno, M. Taima, T. Sumida, Y. Azuma, H. Ogawa, and T. Tanaka, “Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice,” Cancer Letters, vol. 174, no. 2, pp. 141–150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Tanaka, H. Kohno, M. Murakami et al., “Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in beta-cryptoxanthin and hesperidin,” International Journal of Cancer, vol. 88, pp. 146–150, 2000. View at Google Scholar
  20. R. P. Bird and C. K. Good, “The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer,” Toxicology Letters, vol. 112-113, pp. 395–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Tanaka, “Colorectal carcinogenesis: review of human and experimental animal studies,” Journal of Carcinogenesis, vol. 8, article 5, 2009. View at Publisher · View at Google Scholar
  22. J. Raju, “Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer,” World Journal of Gastroenterology, vol. 14, no. 43, pp. 6632–6635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Mori, S. Sugie, N. Yoshimi, A. Hara, and T. Tanaka, “Control of cell proliferation in cancer prevention,” Mutation Research, vol. 428, no. 1-2, pp. 291–298, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Scully, “Oral cancer aetiopathogenesis; past, present and future aspects,” Medicina Oral, Pathologia Oral y Cirugia Bucal, vol. 16, no. 3, pp. e306–e311, 2011. View at Publisher · View at Google Scholar
  25. G. J. Macfarlane, L. Sharp, S. Porter, and S. Franceschi, “Trends in survival from cancers of the oral cavity and pharynx in Scotland: a clue as to why the disease is becoming more common?” British Journal of Cancer, vol. 73, no. 6, pp. 805–808, 1996. View at Google Scholar · View at Scopus
  26. C. H. Shiboski, S. C. Shiboski, and S. Silverman, “Trends in oral cancer rates in the United States, 1973–1996,” Community Dentistry and Oral Epidemiology, vol. 28, no. 4, pp. 249–256, 2000. View at Google Scholar · View at Scopus
  27. C. La Vecchia, F. Lucchini, E. Negri, P. Boyle, P. Maisonneuve, and F. Levi, “Trends of cancer mortality in Europe, 1955–1989: I, digestive sites,” European Journal of Cancer, vol. 28, no. 1, pp. 132–235, 1992. View at Google Scholar · View at Scopus
  28. G. Block, B. Patterson, and A. Subar, “Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence,” Nutrition and Cancer, vol. 18, no. 1, pp. 1–29, 1992. View at Google Scholar · View at Scopus
  29. L. O. Dragsted, “Natural antioxidants in chemoprevention,” Archives of Toxicology, vol. 20, supplement, pp. 209–226, 1998. View at Google Scholar · View at Scopus
  30. M. Pavia, C. Pileggi, C. G. A. Nobile, and I. F. Angelillo, “Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies,” American Journal of Clinical Nutrition, vol. 83, no. 5, pp. 1126–1134, 2006. View at Google Scholar · View at Scopus
  31. E. Riboli and T. Norat, “Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk,” American Journal of Clinical Nutrition, vol. 78, no. 3, supplement, pp. 559S–569S, 2003. View at Google Scholar · View at Scopus
  32. H. Vainio and E. Weiderpass, “Fruit and vegetables in cancer prevention,” Nutrition and Cancer, vol. 54, no. 1, pp. 111–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. S. S. Hecht and N. Trushin, “DNA and hemoglobin alkylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its major metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats,” Carcinogenesis, vol. 9, no. 9, pp. 1665–1668, 1988. View at Google Scholar · View at Scopus
  34. P. Upadhyaya, P. M. J. Kenney, J. B. Hochalter, M. Wang, and S. S. Hecht, “Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse,” Carcinogenesis, vol. 20, no. 8, pp. 1577–1582, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Akopyan and B. Bonavida, “Understanding tobacco smoke carcinogen NNK and lung tumorigenesis (review),” International Journal of Oncology, vol. 29, no. 4, pp. 745–752, 2006. View at Google Scholar · View at Scopus
  36. H. C. Zheng and Y. Takano, “NNK-induced lung tumors: a review of animal model,” Journal of Oncology, vol. 2011, Article ID 635379, 2011. View at Publisher · View at Google Scholar · View at PubMed
  37. S. S. Hecht, “Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis,” Experimental Biology and Medicine, vol. 216, no. 2, pp. 181–191, 1997. View at Google Scholar · View at Scopus
  38. S. S. Hecht, “Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism,” Journal of Nutrition, vol. 129, no. 3, pp. 768S–774S, 1999. View at Google Scholar · View at Scopus
  39. A. K. Bauer, A. M. Malkinson, and S. R. Kleeberger, “Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities,” American Journal of Physiology, vol. 287, no. 4, pp. L685–L703, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. W. T. Gunning, A. Castonguay, P. J. Goldblatt, and G. D. Stoner, “Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens,” Toxicologic Pathology, vol. 19, no. 2, pp. 168–175, 1991. View at Google Scholar · View at Scopus
  41. M. L. Clapper and C. E. Szarka, “Glutathione S-transferases-biomarkers of cancer risk and chemopreventive response,” Chemico-Biological Interactions, vol. 111-112, pp. 377–388, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. A. T. Dinkova-Kostova and P. Talalay, “NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector,” Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 116–123, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. W. D. Holtzclaw, A. T. Dinkova-Kostova, and P. Talalay, “Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers,” Advances in Enzyme Regulation, vol. 44, no. 1, pp. 335–367, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. J. S. Lee and Y. J. Surh, “Nrf2 as a novel molecular target for chemoprevention,” Cancer Letters, vol. 224, no. 2, pp. 171–184, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. B. Pool-Zobel, S. Veeriah, and F. D. Böhmer, “Modulation of xenobiotic metabolising enzymes by anticarcinogens focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis,” Mutation Research, vol. 591, no. 1-2, pp. 74–92, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. P. Talalay, “Chemoprotection against cancer by induction of Phase 2 enzymes,” BioFactors, vol. 12, no. 1-4, pp. 5–11, 2000. View at Google Scholar · View at Scopus
  47. T. Tanaka and R. Suzuki, “Inflammation and cancer,” in Cancer: Disease Progression and Chemoprevention, T. Tanaka, Ed., pp. 27–44, Research Signpost, Kerala, India, 2007. View at Google Scholar
  48. R. Suzuki, S. Miyamoto, Y. Yasui, S. Sugie, and T. Tanaka, “Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate,” BMC Cancer, vol. 7, article 84, 2007. View at Publisher · View at Google Scholar · View at PubMed
  49. Y. Yasui and T. Tanaka, “Protein expression analysis of inflammation-related colon carcinogenesis,” Journal of Carcinogenesis, vol. 8, article 10, 2009. View at Publisher · View at Google Scholar · View at PubMed
  50. P. K. Lala and C. Chakraborty, “Role of nitric oxide in carcinogenesis and tumour progression,” Lancet Oncology, vol. 2, no. 3, pp. 149–156, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. Y. Yasui, K. Mihe, T. Oyama, and T. Tanaka, “Colorectal carcinogensis and suppression of tumor development by inhibition of enzymes and molecular targets,” Current Enzyme Inhibition, vol. 5, no. 1, pp. 1–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Guruswamy and C. V. Rao, “Multi-target approaches in colon cancer chemoprevention based on systems biology of tumor cell-signaling,” Gene Regulation and Systems Biology, vol. 2, pp. 163–176, 2008. View at Google Scholar · View at Scopus
  53. H. Ohshima, H. Tazawa, B. S. Sylla, and T. Sawa, “Prevention of human cancer by modulation of chronic inflammatory processes,” Mutation Research, vol. 591, no. 1-2, pp. 110–122, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. C. V. Rao, “Nitric oxide signaling in colon cancer chemoprevention,” Mutation Research, vol. 555, no. 1-2, pp. 107–119, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. R. Hu, C. L. L. Saw, R. Yu, and A. N. T. Kong, “Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory,” Antioxidants and Redox Signaling, vol. 13, no. 11, pp. 1679–1698, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. J. K. Kundu and Y. J. Surh, “Nrf2-keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis,” Pharmaceutical Research, vol. 27, no. 6, pp. 999–1013, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. L. Shu, K. L. Cheung, T. O. Khor, C. Chen, and A. N. Kong, “Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis,” Cancer and Metastasis Reviews, vol. 29, no. 3, pp. 483–502, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. Y. J. Surh, “NF-κB and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities,” Asia Pacific Journal of Clinical Nutrition, vol. 17, no. 1, pp. 269–272, 2008. View at Google Scholar · View at Scopus
  59. Y. J. Surh, J. K. Kundu, and H. K. Na, “Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals,” Planta Medica, vol. 74, no. 13, pp. 1526–1539, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. Y. Miyagi, A. S. Om, K. M. Chee, and M. R. Bennink, “Inhibition of azoxymethane-induced colon cancer by orange juice,” Nutrition and Cancer, vol. 36, no. 2, pp. 224–229, 2000. View at Google Scholar · View at Scopus
  61. L. K. T. Lam, J. Zhang, S. Hasegawa, and H. A. J. Schut, “Inhibition of chemically induced carcinogenesis by citrus limonoids,” in Food Phytochemicals for Cancer Prevention I. Fruits and Vegetables, M. T. Huang, T. Osawa, C. T. Ho, and R. T. Rosen, Eds., pp. 209–219, American Chemical Society, Washington, DC, USA, 1994. View at Google Scholar
  62. O. S. Sohn, E. S. Fiala, S. P. Requeijo, J. H. Weisburger, and F. J. Gonzalez, “Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol,” Cancer Research, vol. 61, no. 23, pp. 8435–8440, 2001. View at Google Scholar · View at Scopus
  63. M. D. M. Von Pressentin, K. El-Bayoumy, and J. B. Guttenplan, “Mutagenic activity of 4-nitroquinoline-N-oxide in upper aerodigestive tissue in lacZ mice (Muta(TM)Mouse) and the effects of 1,4- phenylenebis(methylene)selenocyanate,” Mutation Research, vol. 466, no. 1, pp. 71–78, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. Z. Serefoglou, C. Yapijakis, E. Nkenke, and E. Vairaktaris, “Genetic association of cytokine DNA polymorphisms with head and neck cancer,” Oral Oncology, vol. 44, no. 12, pp. 1093–1099, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. B. Raju and S. O. Ibrahim, “Pathophysiology of oral cancer in experimental animal models: a review with focus on the role of sympathetic nerves,” Journal of Oral Pathology and Medicine, vol. 40, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. T. Tanaka, H. Kohno, M. Murakami, R. Shimada, and S. Kagami, “Colitis-related rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate (review),” Oncology Reports, vol. 7, no. 3, pp. 501–508, 2000. View at Google Scholar · View at Scopus
  67. D. W. Rosenberg, C. Giardina, and T. Tanaka, “Mouse models for the study of colon carcinogenesis,” Carcinogenesis, vol. 30, no. 2, pp. 183–196, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. B. H. Cohen, E. L. Diamond, C. G. Graves et al., “A common familial component in lung cancer and chronic obstructive pulmonary disease,” The Lancet, vol. 2, no. 8037, pp. 523–526, 1977. View at Google Scholar
  69. T. Kawamori, T. Tanaka, Y. Hirose, M. Ohnishi, and H. Mori, “Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats,” Carcinogenesis, vol. 17, no. 2, pp. 369–372, 1996. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Tanaka, K. Kawabata, M. Kakumoto et al., “Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug- metabolizing enzymes,” Cancer Research, vol. 58, no. 12, pp. 2550–2556, 1998. View at Google Scholar · View at Scopus
  71. T. Tanaka, Y. Yasui, R. Ishigamori-Suzuki, and T. Oyama, “Citrus compounds inhibit inflammation- and obesity-related colon carcinogenesis in mice,” Nutrition and Cancer, vol. 60, no. 1, pp. 70–80, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. T. Tanaka, H. Makita, K. Kawabata et al., “Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin,” Carcinogenesis, vol. 18, no. 5, pp. 957–965, 1997. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Tanaka, M. Maeda, H. Kohno et al., “Inhibition of azoxymethane-induced colon carcinogenesis in male F344 rats by the citrus limonoids obacunone and limonin,” Carcinogenesis, vol. 22, no. 1, pp. 193–198, 2001. View at Google Scholar · View at Scopus
  74. A. Murakami, K. Wada, N. Ueda et al., “In Vitro absorption and metabolism of a citrus chemopreventive agent, auraptene, and its modifying effects on xenobiotic enzyme activities in mouse livers,” Nutrition and Cancer, vol. 36, no. 2, pp. 191–199, 2000. View at Google Scholar · View at Scopus